KK
VNDA icon

Kotler Kevin’s Vanda Pharmaceuticals VNDA Stock Holding History

Kotler Kevin’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$882K Buy
+100,000
New +$550K 0.21% 25

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Kotler Kevin's VNDA Position: Q4 2025 in Review

Kotler Kevin opened a new position in Vanda Pharmaceuticals (VNDA) in Q4 2025: 100,000 shares worth $882K. The stake represents 0.21% of the portfolio and ranks #25 among its holdings.

153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

  • Kotler Kevin held 100,000 shares of Vanda Pharmaceuticals worth $882K as of Q4 2025.
  • Vanda Pharmaceuticals was a new Kotler Kevin position in Q4 2025.
  • Vanda Pharmaceuticals made up 0.21% of Kotler Kevin's portfolio in Q4 2025, its #25 holding.
  • 153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.